不同剂量阿托伐他汀治疗冠心病的临床效果分析被引量：3

下载PDF

导出

摘要目的探讨采用不同剂量阿托伐他汀治疗冠心病的临床疗效。方法选取2012年8月至2013年8月在洛宁县人民医院接受治疗的冠心病患者90例,均采用阿托伐汀进行治疗,根据用药剂量分为两组,各45例,A组采用阿托伐他汀40 mg/d,B组采用阿托伐他汀20 mg/d,比较两组的血脂变化及心绞痛发作次数。结果治疗前,两组血脂差异无统计学意义(P>0.05);治疗后,两组血清TC、TG及LDL-C明显降低,HDL-C明显升高,和治疗前相比差异有统计学意义(P<0.05),且A组变化幅度明显大于B组(P<0.05)。治疗后A组平均心绞痛发作次数低于B组(P<0.05)。结论高剂量阿托伐他汀治疗冠心病,能够有效降低心绞痛发作次数及血脂水平,值得推广应用。

作者郭学武

机构地区洛宁县人民医院心内科

出处《河南医学研究》 CAS 2015年第12期116-117,共2页 Henan Medical Research

关键词冠心病不同剂量阿托伐他汀

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1许力壮,单爱军,刘海华,罗滨.不同剂量阿托伐他汀对冠心病患者冠脉搭桥术后血脂和心功能的影响[J].中国老年学杂志,2013,33(23):5789-5791. 被引量：34
2魏晓芬,韩清华.不同剂量阿托伐他汀对冠心病患者血糖的影响[J].中西医结合心脑血管病杂志,2014,12(7):823-824. 被引量：5
3孙立刚,杨庭树,金琴花,陈韵岱,刘宏斌,陈练,孙志军.不同剂量阿托伐他汀加中药治疗冠状动脉临界病变冠心病患者的前瞻性研究[J].中国医刊,2011,46(3):40-42. 被引量：8
4岳广玺.不同剂量阿托伐他汀治疗冠心病伴颈动脉斑块患者的疗效和安全性评估[J].实用预防医学,2012,19(2):247-248. 被引量：12
5杨章丽,陈良剑.不同剂量阿托伐他汀治疗老年血脂正常冠心病患者的临床疗效分析[J].海南医学,2013,24(14):2044-2046. 被引量：35

二级参考文献49

1谢扬,饶邦复.动脉粥样硬化症与急性冠状动脉综合征[J].现代医药卫生,2004,20(17):1703-1704. 被引量：3
2段军,杨明,丁五麟,邹凤军,张小杭.颈动脉粥样硬化伴多种危险因素的患者与冠心病的关系[J].中国医药导刊,2005,7(5):342-346. 被引量：2
3Waters DD. Medical therapy versus revascularization: the atorvasta-tin versus revascularization treatment AVERT trial [J]. Can J Cardi-ol,2000,16( Suppl A):11A-13A.
4Tikkanen MJ, Holme I, Cater NB, et al. Comparison of efficacy and safety of atorvastatin (80 rag) to simvastatin (20 to 40 mg) in pa-tients aged < 65 versus > or = 65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study) [J]. Am J Cardiol,2009,103(5):577-582.
5LaRosa JC, Deedwania PC, Shepherd J, et al. Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] triM) [J]. Am J Cardiol.2010,105(3):283-287.
6Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarc-tion[J]. J Am Coil Cardiol,2009,54(23):2157-2163.
7Di Sciascio G, Patti G, Paseeri V, et al. Efficacy of atorvastatin re-load in patients on chronic statin therapy undergoing percutancous coronary intervention : results of the ARMYDA-RECAPTURE ( Ator-vastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J]. J Am Coll Cardio1,2009,54(6):558-565.
8Kinlay S, Schwartz GG, Olsson AG, et al. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study [J]. Arterioscler Thromb Vasc Biol,2008,28(1):142-147.
9Lotfi A, Schweiger M J, Giugliano GR, et al. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients-a Pravastatin or Atorvasta-tin Evaluation and Infection Therapy-ThmmlJolysis in Myocardial In- faretion 22 ( PROVE 1T-TIMI 22) analysis[J]. Am Heart J,2008,155(5):954-958.
10杨玉双,李学宇,麻薇,杨萍.兔动脉粥样硬化模型中NO和PAI-1的表达及阿托伐他汀的干预作用[J].吉林大学学报（医学版）,2007,33(4):671-674. 被引量：8